Amgen's most recent trend suggests a bearish bias. One trading opportunity on Amgen is a Bear Call Spread using a strike $167.50 short call and a strike $172.50 long call offers a potential 23.46% return on risk over the next 18 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $167.50 by expiration. The full premium credit of $0.95 would be kept by the premium seller. The risk of $4.05 would be incurred if the stock rose above the $172.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Amgen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Amgen is bearish.
The RSI indicator is at 62.11 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer
Thu, 26 Mar 2015 20:17:12 GMT
noodls – THOUSAND OAKS, Calif., March 26, 2015 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that breast cancer survivor Joan Lunden has been named 2015 Honorary Breakaway from Cancer® Champion as part of …
Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer
Thu, 26 Mar 2015 20:01:00 GMT
PR Newswire – THOUSAND OAKS, Calif., March 26, 2015 /PRNewswire/ — Amgen (AMGN) today announced that breast cancer survivor Joan Lunden has been named 2015 Honorary Breakaway from Cancer® Champion as part of a nationwide search to identify 10 Champions who have made a positive impact in their community. Nominations are being accepted for cancer survivors, patients, caregivers and advocates who have inspired those affected by cancer for the chance to win a trip to the 2015 Amgen Tour of California and be recognized during the final day of America's largest and most prestigious professional cycling race. During Lunden's recent battle with cancer she committed herself to educating women about the importance of screening and early detection. Lunden opened up to the public about her personal journey with the hopes that she could offer support and inspiration and provide a better understanding of the cancer treatment process.
Healthcare Hedge Fund Orbimed’s Top Picks and New Move
Thu, 26 Mar 2015 16:02:25 GMT
The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen – Press Releases
Thu, 26 Mar 2015 13:30:01 GMT
Biotech in nice uptrend: Adami
Wed, 25 Mar 2015 21:00:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook